Clinical Pharmacists and Health Coaches Improve Diabetes Management

By Staff Writer

October 4, 2023

A Collaborative Approach to Diabetes Care

A recent study has shown that clinical pharmacists, in collaboration with health coaches, are making a significant impact on diabetes management and cardiovascular disease risk reduction. They provide comprehensive medication management, addressing adverse effects and drug interactions, assisting in medication taking, and intensifying therapy. The study also highlighted the importance of collaborative action with physicians in improving patient outcomes.

Innovative Methods for Effective Diabetes Management

The study deployed innovative methods to achieve effective diabetes management. Patients were enrolled from primary care clinics within the University of Illinois Hospital. The inclusion criteria ensured that the study targeted African American or Latinx ethnicity, aged between 21 and 75 years, who had been receiving primary care at the clinical site for at least a year. The study utilized mobile health technologies such as telehealth and text messaging to facilitate communication between pharmacists, health coaches, and patients. Pharmacists provided medication management services remotely via videoconferencing, which was facilitated by health coaches using an internet-enabled computer tablet.

Significant Reduction in HbA1c Levels

The results of the study were promising, demonstrating a significant reduction in HbA1c levels among the patients involved. The clinical pharmacist and health coach–delivered mHealth intervention resulted in an HbA1c reduction of 0.79 percentage points. This improvement was not only significant but also sustained, with improvements maintained at 24 months. This indicates that the mHealth-driven intervention is an effective approach to improving blood glucose management. The study’s findings suggest that this strategy may be effective in reducing racial and ethnic disparities in diabetes management.

mHealth Enhances Diabetes Management

The study further demonstrated how mobile health (mHealth), including telehealth and text messaging, can enhance the activities of both pharmacists and health coaches. Pharmacists have used videoconferencing in chronic disease management to improve health care access. This approach may be more effective than text messaging support alone, which has not shown improvement in HbA1c beyond a short duration.

The study concluded that a clinical pharmacist and health coach–delivered mHealth intervention improved HbA1c levels in African American and Latinx patients with T2D over one year compared with usual diabetes care. These improvements sustained themselves at 24 months. Considering this mHealth driven intervention as an effective approach to improve blood glucose management in racial and ethnic minority patients with primary care access in urban environments may be beneficial.

Reference url

Recent Posts

allopurinol Marfan syndrome orphan
       

Allopurinol Designated an Orphan Drug for Marfan Syndrome

🌟 What does the EMA’s orphan drug designation for allopurinol mean for those impacted by Marfan syndrome?

This groundbreaking move highlights a significant step forward in tackling rare diseases, offering hope to patients with limited treatment options. Allopurinol, traditionally used for gout, shows promise in addressing life-threatening aortic complications associated with Marfan syndrome, thanks to its antioxidant properties.

Dive into the implications of this development for healthcare innovation, patient access, and the future of rare disease treatment!

#SyenzaNews #HealthEconomics #Innovation #MarketAccess

marstacimab hemophilia B
                

NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment Landscapes and Economic Implications

💡 Are we witnessing a paradigm shift in hemophilia treatment?

The recent recommendation from NICE for marstacimab as a novel therapy for severe hemophilia B is a game-changer. With its ability to provide effective prophylaxis while potentially lowering treatment costs, this could reshape patient care and health economics in this space.

Dive into the implications this has for patients and healthcare providers, and why marstacimab’s approval could be a pivotal moment for hemophilia management.

Explore the full article for deeper insights!

#SyenzaNews #HealthEconomics #HealthcareInnovation #MarketAccess

HPV-related cancer trends
    

HPV-Related Cancer Trends in South Africa 2011-2021

🌍 Are we witnessing a rise in HPV-related cancer in South Africa?

A recent analysis of data from the South African National Cancer Registry highlights concerning trends: while cervical cancer rates are declining, there’s an alarming rise in non-cervical anogenital cancers. This underscores the urgent need for enhanced cancer prevention and access to efficient healthcare services in the country.

Dive into the findings and explore the implications for health systems and policies.

#SyenzaNews #HealthEconomics #HealthcareInnovation #GlobalHealth

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.